Consolidated Income Statement

Sales

2,743.1

2,469.6

5,307.0

4,947.1

Royalty, license and commission income

109.0

85.8

190.1

172.0

Total revenues

2,852.1

2,555.4

5,497.1

5,119.1

Cost of sales

–807.8

–759.8

–1,556.5

–1,398.8

Gross profit

2,044.3

1,795.5

3,940.5

3,720.3

Marketing and selling expenses

–617.3

–603.8

–1,203.8

–1,193.8

Royalty, license and commission expenses

–151.7

–118.5

–271.7

–229.8

Administration expenses

–142.6

–133.4

–279.0

–264.5

Other operating expenses and income

–488.7

–278.2

–633.2

–215.3

Research and development

–404.0

–368.4

–785.8

–747.2

Amortization of intangible assets

–217.4

–319.0

–433.7

–567.2

Investment result

0.5

2.0

0.5

2.1

Operating result (EBIT)

23.2

–23.7

333.8

504.6

Financial result

–69.7

–76.5

–135.8

–146.6

Profit before income tax

–46.5

–100.1

198.0

358.0

Income tax

–14.1

13.3

–83.4

–103.3

Profit after tax

–60.5

–86.8

114.6

254.7

of which attributable to Merck KGaA shareholders

–63.2

–88.7

109.5

249.7

of which non-controlling interest

2.7

1.9

5.1

5.0

Earnings per share (in €)

basic

–0.29

–0.41

0.50

1.15

diluted

–0.29

–0.41

0.50

1.15